Virginie Vives

1.8k total citations
18 papers, 1.4k citations indexed

About

Virginie Vives is a scholar working on Molecular Biology, Oncology and Orthopedics and Sports Medicine. According to data from OpenAlex, Virginie Vives has authored 18 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Molecular Biology, 12 papers in Oncology and 6 papers in Orthopedics and Sports Medicine. Recurrent topics in Virginie Vives's work include Bone Metabolism and Diseases (10 papers), Bone health and treatments (7 papers) and Bone health and osteoporosis research (6 papers). Virginie Vives is often cited by papers focused on Bone Metabolism and Diseases (10 papers), Bone health and treatments (7 papers) and Bone health and osteoporosis research (6 papers). Virginie Vives collaborates with scholars based in France, United Kingdom and Canada. Virginie Vives's co-authors include Anne Blangy, Catherine Legraverend, Éric Tartour, François Fossiez, Catherine Sautès‐Fridman, Wolf H. Fridman, Alain Gey, Guy Warnier, Fabrice Benchetrit and Nacilla Haicheur and has published in prestigious journals such as Nature Communications, Genes & Development and Blood.

In The Last Decade

Virginie Vives

17 papers receiving 1.4k citations

Peers

Virginie Vives

ONCOL

IMMUN

Meizhang Li United States

Akihisa Fukuda Japan

Susanne Kleber Germany

Marta Rosário Germany

Franca Casagranda Australia

Katherine Fishwick United Kingdom

Emma Fiorini Switzerland

Lucrezia Colonna United States

Norbert Schuster Germany

Kumi Kawai Japan

Meizhang Li United States

Virginie Vives

765 ×1.1

861 ×1.6

ONCOL

549 ×1.1

IMMUN

91 ×0.6

433 ×2.9

Citations per year, relative to Virginie Vives Virginie Vives (= 1×) peers Meizhang Li

Countries citing papers authored by Virginie Vives

Since Specialization

Citations

This map shows the geographic impact of Virginie Vives's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Virginie Vives with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Virginie Vives more than expected).

Fields of papers citing papers by Virginie Vives

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Virginie Vives. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Virginie Vives. The network helps show where Virginie Vives may publish in the future.

Co-authorship network of co-authors of Virginie Vives

This figure shows the co-authorship network connecting the top 25 collaborators of Virginie Vives. A scholar is included among the top collaborators of Virginie Vives based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Virginie Vives. Virginie Vives is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Morel, Anne, et al.. (2024). Bone resorption by osteoclasts involves fine tuning of RHOA activity by its microtubule-associated exchange factor GEF-H1. Frontiers in Physiology. 15. 1342024–1342024.

Blangy, Anne, Guillaume Bompard, David Guérit, et al.. (2020). The osteoclast cytoskeleton – current understanding and therapeutic perspectives for osteoporosis. Journal of Cell Science. 133(13). 50 indexed citations

Morel, Anne, et al.. (2019). Dock5 is a new regulator of microtubule dynamic instability in osteoclasts. Biology of the Cell. 111(11). 271–283. 12 indexed citations

Morel, Anne, Anne Blangy, & Virginie Vives. (2018). Methods to Investigate the Role of Rho GTPases in Osteoclast Function. Methods in molecular biology. 1821. 219–233. 6 indexed citations

Morel, Anne, et al.. (2018). Combined strategy of siRNA and osteoclast actin cytoskeleton automated imaging to identify novel regulators of bone resorption shows a non-mitotic function for anillin. European Journal of Cell Biology. 97(8). 568–579. 6 indexed citations

Vives, Virginie, Christian Richard, Muriel Busson, et al.. (2015). Pharmacological inhibition of Dock5 prevents osteolysis by affecting osteoclast podosome organization while preserving bone formation. Nature Communications. 6(1). 6218–6218. 52 indexed citations

Vives, Virginie, et al.. (2014). The mineral dissolution function of osteoclasts is dispensable for hypertrophic cartilage degradation during long bone development and growth. Developmental Biology. 393(1). 57–70. 29 indexed citations

Blangy, Anne, et al.. (2014). Modulation of osteoclast differentiation and bone resorption by Rho GTPases. Small GTPases. 5(1). e28119–e28119. 73 indexed citations

Royer, Christophe, Virginie Vives, Luca Tordella, et al.. (2010). ASPP2 Binds Par-3 and Controls the Polarity and Proliferation of Neural Progenitors during CNS Development. Developmental Cell. 19(1). 126–137. 93 indexed citations

10.

Vives, Virginie, Mélanie Laurin, Zakia Morichaud, et al.. (2010). The Rac1 exchange factor Dock5 is essential for bone resorption by osteoclasts. Journal of Bone and Mineral Research. 26(5). 1099–1110. 99 indexed citations

11.

Pawlak, Géraldine, et al.. (2008). The Rho GTPase Wrch1 regulates osteoclast precursor adhesion and migration. The International Journal of Biochemistry & Cell Biology. 41(6). 1391–1401. 50 indexed citations

12.

Vives, Virginie, Shan Zhong, Indrika Ratnayaka, et al.. (2006). ASPP2 is a haploinsufficient tumor suppressor that cooperates with p53 to suppress tumor growth. Genes & Development. 20(10). 1262–1267. 80 indexed citations

13.

Vives, Virginie, Elizabeth A. Slee, & Xin Lü. (2006). ASPP2: A Gene that Controls Life and Death in Vivo. Cell Cycle. 5(19). 2187–2190. 22 indexed citations

14.

Aguirre, Adán, et al.. (2005). Spatial and temporal expression of S100B in cells of oligodendrocyte lineage. Glia. 51(2). 81–97. 135 indexed citations

15.

Vives, Virginie, et al.. (2003). Visualization of S100B‐positive neurons and glia in the central nervous system of EGFP transgenic mice. The Journal of Comparative Neurology. 457(4). 404–419. 135 indexed citations

16.

Benchetrit, Fabrice, Virginie Vives, Guy Warnier, et al.. (2002). Interleukin-17 inhibits tumor cell growth by means of a T-cell–dependent mechanism. Blood. 99(6). 2114–2121. 276 indexed citations

17.

Pagès, Franck, Virginie Vives, Catherine Sautès‐Fridman, et al.. (1999). Control of tumor development by intratumoral cytokines. Immunology Letters. 68(1). 135–139. 24 indexed citations

18.

Tartour, Éric, François Fossiez, I Joyeux, et al.. (1999). Interleukin 17, a T-cell-derived cytokine, promotes tumorigenicity of human cervical tumors in nude mice.. PubMed. 59(15). 3698–704. 247 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact